The Risk Factors of the Contraindication Medication of Short-Acting Nifedipine in Hypertensive Patients
碩士 === 中國醫藥大學 === 醫務管理學系碩士班 === 100 === Objective: In recent years, many evidence-based clinical had confirmed that should avoid the use of short-acting nifedipine to treat hypertension. Due to an increased risk of myocardial infarction risk, the purpose of this study was to investigate the risk fac...
Main Authors: | Shih Chang Hsu, 許世昌 |
---|---|
Other Authors: | 黃光華 |
Format: | Others |
Language: | zh-TW |
Published: |
2012
|
Online Access: | http://ndltd.ncl.edu.tw/handle/24780791184529357758 |
Similar Items
-
Long-acting nifedipine in the management of the hypertensive patient
by: Morgan E Snider, et al.
Published: (2008-12-01) -
Contraindications Medication and its Influential Factors of Hypertension Patients with Comorbidities
by: Yun-Wen Sun, et al.
Published: (2012) -
New, long-acting form of nifedipine: efficacy and safety in patients with mild to moderate arterial hypertension
by: E. V. Alimova, et al.
Published: (2004-08-01) -
Old habits die hard: a nationwide utilization study of short-acting nifedipine in Taiwan.
by: Chia-Lin Chou, et al.
Published: (2014-01-01) -
Long-acting nifedipine for hypertensive patients in the Middle East and Morocco: observations on efficacy and tolerability of monotherapy or combination therapy
by: Ghoneim RA, et al.
Published: (2013-06-01)